Assessing Recent Progress Toward Cancer Cures at Perlmutter Cancer Center

May 30, 2018
Benjamin G. Neel, MD, PhD

Benjamin G. Neel, MD, PhD, director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone, discusses how his institution has changed vastly over the last few years, with an increasing number of clinical trials available for patients with lung cancer and other cancers. Clinical trials are often the best option for cancers where the outcomes with conventional treatments may be uncertain, Neel says.

Benjamin G. Neel, MD, PhD, director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone, discusses how his institution has changed vastly over the last few years, with an increasing number of clinical trials available for patients with lung cancer and other cancers. Clinical trials are often the best option for cancers where the outcomes with conventional treatments may be uncertain, Neel says.

Clinical trial operations at Perlmutter Cancer Center have tripled in size, according to Neel. He says that they have also made a great effort in recruiting the most talented investigators across the country.